Dynamic Advisor Solutions’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-552
Closed -$4.37K 978
2024
Q2
$4.37K Hold
552
﹤0.01% 944
2024
Q1
$7.48K Hold
552
﹤0.01% 933
2023
Q4
$5.93K Hold
552
﹤0.01% 899
2023
Q3
$3.59K Hold
552
﹤0.01% 845
2023
Q2
$9.93K Hold
552
﹤0.01% 803
2023
Q1
$13K Sell
552
-50
-8% -$1.26K ﹤0.01% 751
2022
Q4
$15K Hold
602
﹤0.01% 715
2022
Q3
$19K Hold
602
﹤0.01% 677
2022
Q2
$24K Hold
602
﹤0.01% 693
2022
Q1
$24K Buy
602
+83
+16% +$3.06K ﹤0.01% 717
2021
Q4
$26K Buy
519
+56
+12% +$2.99K ﹤0.01% 712
2021
Q3
$30K Buy
463
+50
+12% +$2.16K ﹤0.01% 732
2021
Q2
$16K Hold
413
﹤0.01% 726
2021
Q1
$22K Hold
413
﹤0.01% 659
2020
Q4
$28K Hold
413
﹤0.01% 652
2020
Q3
$16K Hold
413
﹤0.01% 589
2020
Q2
$16K Hold
413
﹤0.01% 534
2020
Q1
$12K Hold
413
﹤0.01% 476
2019
Q4
$47K Hold
413
0.01% 547
2019
Q3
$13K Buy
+413
New +$14.9K ﹤0.01% 518

Other funds holding MTNB

Dynamic Advisor Solutions's MTNB Position: Q3 2024 in Review

Dynamic Advisor Solutions sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 552 shares — an estimated $4.37K sold.

Dynamic Advisor Solutions first reported a position in MTNB in Q3 2019 and held it in 20 quarters. The position peaked at $47K in Q4 2019. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • Dynamic Advisor Solutions reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • Dynamic Advisor Solutions sold 552 Matinas BioPharma shares in Q3 2024, an estimated $4.37K.
  • Dynamic Advisor Solutions first reported a position in Matinas BioPharma in Q3 2019 and held it in 20 quarters.
  • Dynamic Advisor Solutions's Matinas BioPharma position peaked at $47K in Q4 2019.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Dynamic Advisor Solutions's 13F filing for Q3 2024, filed 7 Oct 2024.